-+ 0.00%
-+ 0.00%
-+ 0.00%

FRACTYL HEALTH,.: TO DISCONTINUE INTERNAL DEVELOPMENT OF ITS REJUVA GENE THERAPY PROGRAM ,SEEKING STRATEGIC ALTERNATIVES TO MAXIMIZE VALUE OF PROGRAM

路透·10/22/2026 11:00:00

请登录查看新闻详情